One platform. A growing portfolio of digital therapeutics.
Digital speech therapy for individuals with progressive neurological conditions
-
SpeechATTAX is an evidence-based speech therapy delivered at home. It is designed for individuals with progressive neurological conditions.
The program enables people to undertake intensive speech therapy independently, ensuring flexibility and autonomy while maintaining the therapeutic principles of clinician-led treatment.
SpeechATTAX has been developed through clinical research at the University of Melbourne and evaluated through international clinical studies.
Where We’re Going
Speech is our starting point.
The same challenge that created SpeechATTAX exists throughout healthcare: effective therapies can be difficult to access, difficult to deliver at scale, and constrained by factors such as geography or workforce availability. MDTx is developing a platform to translate traditional therapies into digital interventions. Our development pipeline will extend into new populations and therapeutic domains.
-
Our first therapeutic domain. Beginning with SpeechATTAX, we are exploring how digital delivery can improve access to evidence-based communication therapies. MDTx addresses a number of neurological conditions affecting speech.
-
Families often face significant barriers to accessing frequent and sustained therapy. We see opportunities to develop age-appropriate digital interventions that complement clinical care, and enable therapeutic activities within everyday life.
-
We are exploring opportunities to translate evidence-based cognitive interventions into digital therapies. MDTx aims to enable delivery beyond clinical settings.
-
Physical therapies often require sustained engagement and frequent practice. Future MDTx products will explore how digital delivery can support evidence-based approaches to movement, mobility and rehabilitation.
The next generation of therapeutics.
We are interested in more than developing our own products.
MDTx provides a foundation for working with clinicians, researchers, healthcare organisations and commercial partners to identify promising therapeutic approaches, and translate them into scalable digital interventions.
If you have an evidence-based therapy that could reach more people through digital delivery, we would like to hear from you.
“My speech improved so much… that friends complimented me on the clarity of my diction.”
– Terry O’Hanlon, SpeechATTAX User